HB 163 KY

0likes☆Favorite🔕SubscribeShare

Introduced

Amend KRS 214.450 to define "COVID-19 vaccine" or "mRNA vaccine"; amend KRS 214.452 to require blood establishments to test for COVID-19 antibodies, evidence of lipid nanoparticles, and spike protein; require the administrator of any blood establishment to inquire on the donor history questionnaire whether a donor has received a COVID-19 vaccine or mRNA vaccine; require a donor to provide the name of the manufacturer of the COVID-19 vaccine the donor received; establish deferral periods for donors who have received a live attenuated COVID-19 vaccine or for donors who do not know the manufacturer of the COVID-19 vaccine the donor received, and establish deferral periods for donors who have received a diagnosis of COVID-19 or are displaying symptoms of COVID-19; amend KRS 214.458 to require blood establishments to include on the label for blood collected the laboratory test results for COVID-19.

• J. Decker Republican · primary
• E. Callaway Republican · primary
• S. Dietz Republican · primary
• D. Fister Republican · primary
• D. Hale Republican · primary
• M. Imes Republican · primary
• DJ Johnson Republican · primary
• M. Lockett Republican · primary
• S. McPherson Republican · primary
• K. Moser Republican · primary
• R. Raymer Republican · primary
• N. Tate Republican · primary
• T. Truett Republican · primary
• R. White Republican · primary

1. Jan 5, 2024 introduced in House · lower
2. Jan 5, 2024 to Committee on Committees (H) · lower

The published texts of this bill as it moves through the legislature. Each links to the official document on the state legislature site. Data from OpenStates.

• Introduced · PDF